Findings

What do systematic reviews say?

4 questions · 4 findings · 2 reviews · Haematology

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 25%Moderate 3 · 75%High 0 · 0%

Relapse, progression or death (calculated instead of PFS) · Patients with early unfavourable or advanced stage HL

Escalated BEACOPP probably leads to lower progression, relapse or death compared with chemotherapy including ABVD (moderate certainty).

1 finding from 1 review

Relapse, progression or death (calculated instead of PFS)

The intervention probably leads to lower relapse, progression or death (calculated instead of PFS) (moderate certainty).

1 finding from 1 review

Relapse, progression or death (calculated instead of PFS)

The intervention showed no clear difference in relapse, progression or death (calculated instead of PFS) (low certainty).

1 finding from 1 review

Relapse, progression or death (calculated instead of PFS) sensitivity analysis ‐ without HD6trial due to high risk of other bias

The intervention probably leads to lower relapse, progression or death (calculated instead of PFS)… (moderate certainty).

1 finding from 1 review